Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × anlotinib × Clear all

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Phase 1/2 Unknown

Nasopharyngeal Carcinoma